Home  >  Research  >  Labs  >  Cancer Program

OVERVIEW

The Cancer Program is led by Associate Professor Pilar Blancafort.

Perkins researchers have made major discoveries in the field of cancer including uncovering the SLIRP gene which controls hormone production in breast and prostate cancers, the tumour suppressor gene HLS5 and a process for normalising blood vessels in tumours to allow more effective absorption of cancer-combating drugs. Detailed information about our cancer laboratories can be found below.

Associate Professor Pilar Blancafort

Associate Professor Pilar Blancafort

Cancer Epigenetics (Program Head - Cancer)

Read more

RESEARCH NEWS & EVENTS

Dr Moira Clay takes up new Deputy Director role at the Perkins

The Harry Perkins Institute of Medical Research is delighted to welcome Dr Moira Clay as Deputy Director. Moira will commence in this new role on 4 February 2025. Moira will…

Read More

Researchers discover blood markers that could predict mesothelioma treatment success

A groundbreaking study by researchers at the National Centre for Asbestos Related Diseases (NCARD), The Kids Research Institute and the Harry Perkins Institute of Medical Research (the Perkins) has identified…

Read More

Perkins researcher awarded Raine Priming Grant

Dr Mridul Johari from the Perkins Rare Disease Genetics and Functional Genomics Group has been awarded a prestigious Raine Priming Grant from the Raine Medical Research Foundation. Dr Johari’s project,…

Read More

Help WA's best medical researchers beat the world's toughest diseases.